Contrast enhanced transesophageal echocardiographic guidance of left atrial appendage closure device implantation

Michael L Main1, George G Latus, Anthony Magalski

  • 1Saint Luke's Mid America Heart Institute, Kansas City, MO, USA. mmain@cc-pc.com

Insights

Percutaneous left atrial appendage closure offers an alternative to anticoagulation for stroke risk in atrial fibrillation. Contrast-enhanced transesophageal echocardiography precisely guided device implantation, enabling warfarin cessation.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Procedures

Background:

  • Nonvalvular atrial fibrillation increases stroke risk, often managed with oral anticoagulation.
  • Left atrial appendage (LAA) closure devices provide an alternative to anticoagulation.
  • Transesophageal echocardiography (TEE) is crucial for LAA assessment and device guidance.

Observation:

  • A case study involving a patient with nonvalvular atrial fibrillation requiring LAA closure.
  • Challenges in defining LAA anatomy for optimal device placement were noted.
  • Contrast-enhanced TEE was employed to overcome these anatomical challenges.

Findings:

  • Contrast-enhanced TEE provided critical spatial resolution of LAA borders.
  • This enhanced visualization facilitated precise device implantation.
  • Successful LAA closure led to the cessation of warfarin therapy.

Implications:

  • Contrast-enhanced TEE is a valuable tool for complex LAA closure procedures.
  • This technique can improve procedural success rates and patient outcomes.
  • It expands treatment options for patients with atrial fibrillation unsuitable for long-term anticoagulation.